The YUMM lines: a series of congenic mouse melanoma cell lines with defined genetic alterations
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The YUMM lines: a series of congenic mouse melanoma cell lines with defined genetic alterations
Authors
Keywords
-
Journal
Pigment Cell & Melanoma Research
Volume 29, Issue 5, Pages 590-597
Publisher
Wiley
Online
2016-06-11
DOI
10.1111/pcmr.12498
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Type I-polarized BRAF-pulsed dendritic cells induce antigen-specific CD8+ T cells that impact BRAF-mutant murine melanoma
- (2016) Jessica A. Cintolo et al. MELANOMA RESEARCH
- sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance
- (2016) Amanpreet Kaur et al. NATURE
- mTORC1 Activation Blocks BrafV600E-Induced Growth Arrest but Is Insufficient for Melanoma Formation
- (2015) William Damsky et al. CANCER CELL
- Blocking Tumor Necrosis Factor Enhances CD8 T-cell-Dependent Immunity in Experimental Melanoma
- (2015) F. Bertrand et al. CANCER RESEARCH
- PDK1 and SGK3 Contribute to the Growth of BRAF-Mutant Melanomas and Are Potential Therapeutic Targets
- (2015) M. Scortegagna et al. CANCER RESEARCH
- Phosphoenolpyruvate Is a Metabolic Checkpoint of Anti-tumor T Cell Responses
- (2015) Ping-Chih Ho et al. CELL
- The BRAFV600E inhibitor, PLX4032, increases type I collagen synthesis in melanoma cells
- (2015) Molly H. Jenkins et al. MATRIX BIOLOGY
- Therapy-induced tumour secretomes promote resistance and tumour progression
- (2015) Anna C. Obenauf et al. NATURE
- Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens
- (2014) Matthew M. Gubin et al. NATURE
- Transcriptome sequencing of melanocytic nevi and melanomas fromGrm1transgenic mice to determine melanoma driver mutations
- (2014) Miriam M. de Jel et al. Pigment Cell & Melanoma Research
- Multiple murine BRafV600Emelanoma cell lines with sensitivity to PLX4032
- (2014) Molly H. Jenkins et al. Pigment Cell & Melanoma Research
- Isolation and Molecular Characterization of Circulating Melanoma Cells
- (2014) Xi Luo et al. Cell Reports
- CRM1 and BRAF Inhibition Synergize and Induce Tumor Regression in BRAF-Mutant Melanoma
- (2013) R. A. Salas Fragomeni et al. MOLECULAR CANCER THERAPEUTICS
- Genetic inactivation or pharmacological inhibition of Pdk1 delays development and inhibits metastasis of Braf V600E ::Pten –/– melanoma
- (2013) M Scortegagna et al. ONCOGENE
- Cancer–stromal cell interactions mediated by hypoxia-inducible factors promote angiogenesis, lymphangiogenesis and metastasis
- (2012) G L Semenza ONCOGENE
- β-Catenin Signaling Controls Metastasis in Braf-Activated Pten-Deficient Melanomas
- (2011) William E. Damsky et al. CANCER CELL
- The Canonical NF- B Pathway Governs Mammary Tumorigenesis in Transgenic Mice and Tumor Stem Cell Expansion
- (2010) M. Liu et al. CANCER RESEARCH
- Cooperative interactions of PTEN deficiency and RAS activation in melanoma metastasis
- (2010) C Nogueira et al. ONCOGENE
- Targeted delivery of NRASQ61R and Cre-recombinase to post-natal melanocytes induces melanoma in Ink4a/Arflox/lox mice
- (2010) Matthew W. VanBrocklin et al. Pigment Cell & Melanoma Research
- BrafV600E cooperates with Pten loss to induce metastatic melanoma
- (2009) David Dankort et al. NATURE GENETICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search